MNTA’s share of the Lovenox collaboration’s profit is 45% (not 50%), so your $150M estimate for the collaboration’s 1Q11 profit would mean $68M (not $75M) for MNTA’s share.
when do you think we get some meaningful update on the FoB and M118 programs?
Pretty soon for the former, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”